Tirzepatide Insurance Coverage

Zepbound coverage for weight management is expanding rapidly but remains inconsistent. As of 2026, an estimated 35-45% of commercially insured Americans have some access to Zepbound coverage. Eli Lilly has invested heavily in employer education and formulary negotiations.

Coverage criteria typically require BMI >= 30 (or >= 27 with comorbidities), documentation of prior weight management attempts, and prior authorization. Some plans impose quantity limits or require re-authorization every 6-12 months with documented weight loss progress.

For patients without insurance coverage, Eli Lilly's LillyDirect platform offers Zepbound single-dose vials at significantly reduced prices compared to retail pharmacy pricing. Starting at $399/month for lower doses, LillyDirect provides a brand-name option that bypasses insurance entirely.

This program has been a game-changer for patients who are denied insurance coverage or face prohibitive copays. The ordering process is online, prescriptions can be transferred, and medication ships directly to patients. This is not a generic or compounded product -- it's brand Zepbound from Eli Lilly.

The Zepbound Savings Card can reduce monthly costs to as low as $25 for commercially insured patients, covering up to $563 per fill. The Mounjaro Savings Card offers similar terms for diabetes patients. These cards are available for patients with commercial insurance (not Medicare, Medicaid, or government programs).

Eli Lilly's Solutions Center helps patients navigate insurance, find savings options, and apply for patient assistance programs. For uninsured patients meeting income criteria, the Lilly Patient Assistance Program may provide free medication.

To maximize your chances of insurance approval for tirzepatide: ensure comprehensive medical documentation including BMI, comorbidities (hypertension, sleep apnea, dyslipidemia, PCOS, etc.), prior weight management attempts, and the impact of obesity on quality of life. If denied, always appeal.

Some patients have success getting Mounjaro covered for diabetes and receiving weight loss as a secondary benefit. If you have prediabetes or insulin resistance, this approach may provide access to tirzepatide even if your plan doesn't cover weight loss medications specifically.